The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Mallinckrodt Plc

NYSE: MNK
Last

(U.S.) $122.01

Today's change0.00 0.00%
Updated April 24 4:03 PM EDT. Delayed by at least 15 minutes.
 

Mallinckrodt Plc

NYSE: MNK
Last

(U.S.) $122.01

Today's change0.00 0.00%
Updated April 24 4:03 PM EDT. Delayed by at least 15 minutes.

Mallinckrodt Plc closed at (U.S.)$122.01.

Shares have lost 0.30% over the last five days, but have gained 23.21% over the last year to date. This security has outperformed the S&P 500 by 67.74% during the last year.

Key company metrics

  • Open(U.S.) $124.15
  • Previous close(U.S.) $122.01
  • High(U.S.) $124.65
  • Low(U.S.) $121.71
  • Bid / Ask-- / --
  • YTD % change+23.21%
  • Volume946,082
  • Average volume (10-day)1,302,426
  • Average volume (1-month)1,367,060
  • Average volume (3-month)1,283,029
  • 52-week range(U.S.) $64.50 to (U.S.) $134.26
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward16.76×
  • Forward PEG0.60×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$3.57
Updated April 24 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-9.52%

Mallinckrodt Plc has a net profit margin of -9.52%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 26, 201412/26/2014Sep 26, 201409/26/2014Jun 27, 201406/27/2014Mar 28, 201403/28/2014
Revenue866789653558
Total other revenue--------
Total revenue866789653558
Gross profit439401284263
Total cost of revenue428389369295
Total operating expense7391,146658554
Selling / general / administrative263281221194
Research & development42444341
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)64302321
Other operating expenses, total0323
Operating income127-357-44
Interest income (expense), net non-operating-49-38-23-12
Gain (loss) on sale of assets--------
Other--------
Income before tax83-391-27-9
Income after tax92-352-2412
Income tax, total-9-39-2-20
Net income93-352-2412
Total adjustments to net income--------
Net income before extra. items92-352-2412
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items92-352-2412
Inc. avail. to common incl. extra. items93-352-2412
Diluted net income93-352-2412
Dilution adjustment--000
Diluted weighted average shares116855959
Diluted EPS excluding extraordinary itemsvalue per share0.79-4.15-0.420.20
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.83-0.86-0.160.43